bg
B

Bioatla (BCAB)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Bioatla (BCAB)

BioAtla, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

  • USD3.28
  • USD3.32
  • USD3.14
  • USD4.07
  • 17.50%
  • --
  • 334.76k
  • 769.39k
  • 183M
  • 1.24
  • -6.90%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.